Linkage Projects - Grant ID: LP100200500

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP100200500

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Designing dendrimer-based lymphatic drug vectors as improved treatments for metastatic cancer. This project builds on areas of research strength in Australia (nanotechnology and biotechnology/biomaterials) and will add considerably to the expanding Australian expertise-base in dendrimer technology (in which it is a world leader). The project will advance the fundamental science base that underpins dendrimer design and has the potential to deliver substantial benefits in improved drug delivery and therefore health outcomes for Australia. The interdisciplinary nature of this project will also result in a unique training program for the researchers involved. Such experience is in great demand in Australia where the developing biotechnology and nanotechnology industry is critically short of scientists with skills in drug delivery.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Linkage Projects

Funding Amount: $410,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmaceutical Sciences | Macromolecular and Materials Chemistry | Nanochemistry and Supramolecular Chemistry

ANZSRC Socio-Economic Objective (SEO)

Human Diagnostics | Human Pharmaceutical Treatments (e.g. Antibiotics) |

Other Keywords

Human Diagnostics | Human Pharmaceutical Treatments (e.g. Antibiotics) | Macromolecular and Materials Chemistry | Nanochemistry and Supramolecular Chemistry | Pharmaceutical Sciences

Related Links